# Teriparatide

## Forteo 750mcg/3mL 28dose

| 藥物代碼 | IFOR7 |
| :--- | :--- |
| 適應症 | Treatment of postmenopausal women with osteoporosis who are at high risk for fracture. To increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture. |
| 副作用 | GI disturbances, asthenia, hypotension, arthralgia, leg cramps, dizziness, depression, insomnia, vertigo, rhinitis, cough, pharyngitis, dyspnea, rash, increased sweating, hypercalcemia.Cardiovascular: Hypotension, SyncopeDermatologic: Rash, Sweating symptomEndocrine metabolic: HyperuricemiaGastrointestinal: Constipation, Diarrhea, Indigestion, Nausea, VomitingMusculoskeletal: Arthralgia \(10.1% \), Spasm \(1% to 10% \)Neurologic: Asthenia, DizzinessRespiratory: Increasing frequency of cough, Pharyngitis, Rhinitis |
| 禁忌 | Paget's disease of bone, unexplained elevations of alkaline phosphatase, prior history of radiation therapy involving the skeleton, bone metastases or a history of skeletal malignancies, metabolic bone diseases \(other than osteoporosis\), pre-existing hypercalcemia, children or adolescents with open epiphyses. |
| 藥物保存方式 | 2-8℃ |
| 用法用量 | 20 mcg once daily. By SC inj into the thigh or abdominal wall. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | SC |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | 2020/10/30:詢問廠商後告知25度C以下可保24小時安定. |

